Christa Pike’s Lawyers Raised Alarm Over Possible Rare Blood Cancer Months Before Botched Execution

Newly reported court documents have revealed that attorneys for death row inmate Christa Pike raised concerns about a possible rare blood disorder months before Tennessee attempted to execute her by lethal injection.

Pike, 50, survived a failed execution on September 30, 2026, after prison officials administered two doses of the powerful sedative pentobarbital. The procedure was halted when she remained alive, and she was rushed to a Nashville hospital in critical condition.

According to a January 8 court filing obtained by PEOPLE, Pike’s legal team warned that she might have myeloproliferative disorder, a rare group of blood cancers in which the bone marrow produces excessive numbers of blood cells.

The filing pointed to her significantly elevated platelet count, a condition known as thrombocytosis. Her attorneys argued that the suspected disorder could increase her risk of developing pulmonary edema, a potentially life-threatening buildup of fluid in the lungs.

They warned that this complication could cause severe breathing difficulties and an intense sensation of suffocation during the execution.

The lawyers also raised concerns about Pike’s history of difficult blood draws and problems with needle insertion. They argued that these medical issues could make establishing intravenous access particularly challenging and increase the risk of additional pain during the procedure.

It remains unclear whether Pike has received a confirmed diagnosis of myeloproliferative disorder. The January filing described the condition as a suspected explanation for her abnormal blood test results, rather than establishing a definitive diagnosis.

Those concerns became particularly significant during the September execution attempt. Reports indicated that execution personnel struggled to establish intravenous lines, with multiple needle attempts made before the lethal-injection drugs were administered.

Despite receiving two doses of pentobarbital, Pike survived. She was hospitalized for approximately 10 days before being discharged on October 9 and returned to the Debra K. Johnson Rehabilitation Center in Tennessee.

Her recovery has reportedly been difficult. In her first public statement following the failed execution, released on October 30, Pike said she had experienced constant pain since the night of the procedure.

“There hasn’t been a moment since that night when I haven’t been in pain,” she said, describing injuries affecting her body, arms, hands and throat. She also said she continued to struggle with speaking.

Pike’s attorneys have separately challenged her continued isolation in the prison medical ward, arguing that the conditions violate a previous settlement agreement. They say she has been denied opportunities to socialize and participate in ordinary prison activities.

Pike was sentenced to death in 1996 for the 1995 torture and murder of 19-year-old Colleen Slemmer, a fellow student at a Tennessee Job Corps center. Pike was 18 when the crime occurred.

The failed execution has prompted a broader review of Tennessee’s lethal-injection procedures. Governor Bill Lee suspended the state’s remaining executions for 2026 while an independent investigation examines the incident.

The newly reported medical concerns raise further questions about what prison officials knew before the execution and whether Pike’s health conditions were adequately considered. Her possible blood cancer diagnosis, however, has not been independently confirmed in the available reporting.

Source:  DAILYMAIL